[RFA-DC-26-001] Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)
National Institutes of Health
Deadline
17 June 2027
Description
Titolo: Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional) Numero dell'opportunità: RFA-DC-26-001 Stato: aperto (posted) Tipo di opportunità: Discretionary Ente: National Institutes of Health — Department of Health and Human Services Tipo di finanziamento: Grant Categoria: Health Programma (ALN): 93.173 Research Related to Deafness and Communication Disorders Pubblicato il: 2026-02-05 Scadenza per le domande: 2027-06-17 Finanziamento totale stimato: 1,000,000 USD Cofinanziamento richiesto: no Chi può fare domanda: Others (see text field entitled "Additional Information on Eligibility" for clarification); State governments; City or township governments; Native American tribal organizations (other than Federally recognized tribal governments); Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Independent school districts; Private institutions of higher education; For profit organizations other than small businesses; Small businesses; Native American tribal governments (Federally recognized); Special district governments; Public and State controlled institutions of higher education; Public housing authorities/Indian housing authorities; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; County governments Altre condizioni di eleggibilità: Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.NIH will no longer issue awards (i.e., new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/subcontracts. All NIH-funded research involving foreign subawards/subcontracts must be submitted in response to a NOFO that is specifically designated for funded international collaborations. This new requirement was effective, May 1, 2025.Applications involving foreign subawards/subcontracts submitted in response to this NOFO will be deemed noncompliant and will not be considered for funding. This policy applies to all monetary international collaborations resulting in foreign subawards/subcontracts, however, it does not preclude unfunded international collaborations or foreign components, funding for foreign consultants, or procurement of unique equipment or supplies from foreign vendors.
Sectors
Want to know if this call is right for you?
Sign up free: Bandolo compares the call with your profile, company or professional, and tells you how well it fits.
Sign up free